Insider Trading activities of Nuvectra Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nuvectra Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nuvectra Corp since year 2005. Table 2 shows the detailed insider transactions of Nuvectra Corp since 2005. The reporting company's ticker symbol is NVTR. The reporting company's CIK number is 1648893.
The total value of stock buying since 2005 is $1,097,301.
The total value of stock sales since 2005 is $2,207.
The total value of stock option exercises since 2005 is $1,867,886.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nuvectra Corp (NVTR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 0 $0 4,665 $18,706
2017-10 0 $0 0 $0 34,709 $469,009
2017-08 10,000 $117,200 0 $0 0 $0
2017-07 0 $0 0 $0 35,707 $462,063
2017-05 10,000 $102,810 0 $0 0 $0
2017-04 0 $0 0 $0 124,404 $791,204
2017-03 67,000 $412,354 0 $0 0 $0
2017-02 0 $0 0 $0 1,123 $5,783
2017-01 0 $0 412 $2,207 5,859 $32,690
2016-12 0 $0 0 $0 1,526 $7,672
2016-10 0 $0 0 $0 5,873 $38,346
2016-07 0 $0 0 $0 5,859 $42,413
2016-05 30,000 $464,937 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nuvectra Corp insiders (NVTR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-04 Miller Joseph A (Director) Option Ex 4,665 4.01 18,706
2017-10-10 Tremmel Jon T (Director) Option Ex 838 13.87 11,623
2017-10-10 Zelibor Thomas Edward (Director) Option Ex 838 13.87 11,623
2017-10-10 Bihl Anthony P Iii (Director) Option Ex 838 13.87 11,623
2017-10-10 Parks Fred B (Director) Option Ex 838 13.87 11,623
2017-10-10 Miller Joseph A (Director) Option Ex 838 13.87 11,623
2017-10-10 Johnson David D (Director) Option Ex 838 13.87 11,623
2017-10-10 Hawari Kenneth G (Director) Option Ex 838 13.87 11,623
2017-10-07 Hanchin Joseph Paul (President) Option Ex 4,278 13.44 57,496
2017-10-07 Kaula Norbert (EVP, Research & Development) Option Ex 499 13.44 6,706
2017-10-07 Drees Scott F (CEO) Option Ex 16,044 13.44 215,631
2017-10-07 Berger Walter Z (CFO) Option Ex 8,022 13.44 107,815
2017-08-11 Drees Scott F (CEO) Buy 10,000 11.72 117,200
2017-07-25 Hickman Thomas Kelley (EVP, Sales & Marketing) Option Ex 499 11.92 5,948
2017-07-10 Tremmel Jon T (Director) Option Ex 838 12.73 10,667
2017-07-10 Zelibor Thomas Edward (Director) Option Ex 838 12.73 10,667
2017-07-10 Bihl Anthony P Iii (Director) Option Ex 838 12.73 10,667
2017-07-10 Parks Fred B (Director) Option Ex 838 12.73 10,667
2017-07-10 Miller Joseph A (Director) Option Ex 838 12.73 10,667
2017-07-10 Johnson David D (Director) Option Ex 838 12.73 10,667
2017-07-10 Hawari Kenneth G (Director) Option Ex 838 12.73 10,667
2017-07-07 Hanchin Joseph Paul (President) Option Ex 4,278 13.00 55,614
2017-07-07 Kaula Norbert (EVP, Research & Development) Option Ex 499 13.00 6,487
2017-07-07 Hickman Thomas Kelley (EVP, Sales & Marketing) Option Ex 499 13.00 6,487
2017-07-07 Drees Scott F (CEO) Option Ex 16,044 13.00 208,572
2017-07-07 Berger Walter Z (CFO) Option Ex 8,022 13.00 104,286
2017-05-30 Drees Scott F (CEO) Buy 7,395 10.41 76,981
2017-05-25 Drees Scott F (CEO) Buy 1,700 9.95 16,915
2017-05-24 Drees Scott F (CEO) Buy 905 9.85 8,914
2017-04-07 Hanchin Joseph Paul (President) Option Ex 17,104 6.36 108,781
2017-04-07 Kaula Norbert (EVP, Research & Development) Option Ex 1,995 6.36 12,688
2017-04-07 Fahey Kathy Jo (VP of Regulatory & Clinical) Option Ex 1,247 6.36 7,930
2017-04-07 Hickman Thomas Kelley (EVP, Sales & Marketing) Option Ex 1,995 6.36 12,688
2017-04-07 Tremmel Jon T (Director) Option Ex 837 6.36 5,323
2017-04-07 Zelibor Thomas Edward (Director) Option Ex 837 6.36 5,323
2017-04-07 Bihl Anthony P Iii (Director) Option Ex 837 6.36 5,323
2017-04-07 Parks Fred B (Director) Option Ex 837 6.36 5,323
2017-04-07 Miller Joseph A (Director) Option Ex 837 6.36 5,323
2017-04-07 Johnson David D (Director) Option Ex 837 6.36 5,323
2017-04-07 Drees Scott F (CEO) Option Ex 64,136 6.36 407,904
2017-04-07 Berger Walter Z (CFO) Option Ex 32,068 6.36 203,952
2017-04-07 Hawari Kenneth G (Director) Option Ex 837 6.36 5,323
2017-03-16 Miller Joseph A (Director) Buy 25,000 6.11 152,750
2017-03-16 Hawari Kenneth G (Director) Buy 17,000 6.14 104,380
2017-03-14 Drees Scott F (CEO) Buy 17,100 6.19 105,849
2017-03-13 Drees Scott F (CEO) Buy 7,900 6.25 49,375
2017-02-22 Miller Joseph A (Director) Option Ex 1,123 5.15 5,783
2017-01-07 Tremmel Jon T (Director) Option Ex 837 5.58 4,670
2017-01-07 Zelibor Thomas Edward (Director) Option Ex 837 5.58 4,670
2017-01-07 Bihl Anthony P Iii (Director) Option Ex 837 5.58 4,670
2017-01-07 Parks Fred B (Director) Option Ex 837 5.58 4,670
2017-01-07 Miller Joseph A (Director) Option Ex 837 5.58 4,670
2017-01-07 Johnson David D (Director) Option Ex 837 5.58 4,670
2017-01-07 Hawari Kenneth G (Director) Option Ex 837 5.58 4,670
2017-01-04 Fahey Kathy Jo (VP of Regulatory & Clinical) Sale 186 5.36 996
2017-01-04 Hickman Thomas Kelley (EVP, Sales & Marketing) Sale 133 5.36 713
2016-12-30 Kaula Norbert (EVP, Research & Development) Option Ex 277 5.03 1,393
2016-12-30 Fahey Kathy Jo (VP of Regulatory & Clinical) Option Ex 528 5.03 2,654
2016-12-30 Hickman Thomas Kelley (EVP, Sales & Marketing) Option Ex 457 5.03 2,298
2016-10-07 Tremmel Jon T (Director) Option Ex 839 6.53 5,478
2016-10-07 Zelibor Thomas Edward (Director) Option Ex 839 6.53 5,478
2016-10-07 Bihl Anthony P Iii (Director) Option Ex 839 6.53 5,478
2016-10-07 Parks Fred B (Director) Option Ex 839 6.53 5,478
2016-10-07 Miller Joseph A (Director) Option Ex 839 6.53 5,478
2016-10-07 Johnson David D (Director) Option Ex 839 6.53 5,478
2016-10-07 Hawari Kenneth G (Director) Option Ex 839 6.53 5,478
2016-07-07 Tremmel Jon T (Director) Option Ex 837 7.24 6,059
2016-07-07 Zelibor Thomas Edward (Director) Option Ex 837 7.24 6,059
2016-07-07 Bihl Anthony P Iii (Director) Option Ex 837 7.24 6,059
2016-07-07 Parks Fred B (Director) Option Ex 837 7.24 6,059
2016-07-07 Miller Joseph A (Director) Option Ex 837 7.24 6,059
2016-07-07 Johnson David D (Director) Option Ex 837 7.24 6,059
2016-07-07 Hawari Kenneth G (Director) Option Ex 837 7.24 6,059
2016-05-19 Johnson David D (Director) Buy 27,363 7.46 203,991
2016-05-18 Johnson David D (Director) Buy 2,637 98.96 260,946

Insider trading activities including stock purchases, stock sales, and option exercises of NVTR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nuvectra Corp (symbol NVTR, CIK number 1648893) see the Securities and Exchange Commission (SEC) website.